NSUN2介导SALL2 m5C甲基化抑制铁下垂并促进乳腺癌进展。

IF 5.7 4区 医学 Q2 ONCOLOGY
Cancer Biology & Therapy Pub Date : 2026-12-31 Epub Date: 2026-06-30 DOI:10.1080/15384047.2026.2695501
Jiawei Li, Min Li, Jianran Guo, Dongbao Li, Yumin Yao, Wei Zhang, Chuanyou Cui, Bo Fu
{"title":"NSUN2介导SALL2 m5C甲基化抑制铁下垂并促进乳腺癌进展。","authors":"Jiawei Li, Min Li, Jianran Guo, Dongbao Li, Yumin Yao, Wei Zhang, Chuanyou Cui, Bo Fu","doi":"10.1080/15384047.2026.2695501","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Due to the heterogeneity of breast cancer (BRCA) and the limited therapeutic efficacy in specific molecular subtypes, identifying new and effective therapeutic targets remains an urgent clinical need. The transcription factor <i>SALL2</i> has been shown to play distinct roles in tumorigenesis and progression, but its specific role in BRCA remains unclear. Therefore, this study investigates the effects of <i>SALL2</i> on BRCA progression.</p><p><strong>Methods: </strong><i>SALL2</i> expression in the TCGA and clinical BRCA tissue samples was analyzed. Cell and animal models were established to validate the effects of <i>SALL2</i> on BRCA cell proliferation, migration, and tumorigenicity. Molecular experiments were performed to investigate the association between NSUN2 and SALL2 in BRCA and cellular ferroptosis regulation by SALL2.</p><p><strong>Results: </strong><i>SALL2</i> is significantly overexpressed in BRCA tissues and cell lines, knocking down <i>SALL2</i> reduces BRCA cell growth, migration, and tumorigenesis <i>in vitro</i> and <i>in vivo</i> models. The m5C methyltransferase NSUN2, together with the reader protein YBX1, modifies <i>SALL2</i> mRNA with m5C, which stabilizes the transcript. <i>SALL2</i> then acts as a transcriptional repressor by binding directly to the promoter region of <i>ACSL4</i> and inhibiting its transcriptional activity. Suppression of <i>SALL2</i> activates ferroptotic cell death by lowering the antioxidant defences of GPX4/SLC7A11 and increasing the expression of <i>ACSL4</i> and <i>COX2</i>. Ferroptosis inhibitors can reverse the growth-inhibiting effects caused by <i>SALL2</i> depletion.</p><p><strong>Conclusion: </strong>In BRCA, <i>SALL2</i> is precisely regulated by m5C RNA methylation modification, further promoting cancer progression by inhibiting cell ferroptosis, suggesting its potential as a prognostic biomarker and a target for therapy.</p>","PeriodicalId":9536,"journal":{"name":"Cancer Biology & Therapy","volume":"27 1","pages":"2695501"},"PeriodicalIF":5.7000,"publicationDate":"2026-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13327353/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>NSUN2</i> mediates <i>SALL2</i> m5C methylation to inhibit ferroptosis and promote breast cancer progression.\",\"authors\":\"Jiawei Li, Min Li, Jianran Guo, Dongbao Li, Yumin Yao, Wei Zhang, Chuanyou Cui, Bo Fu\",\"doi\":\"10.1080/15384047.2026.2695501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Due to the heterogeneity of breast cancer (BRCA) and the limited therapeutic efficacy in specific molecular subtypes, identifying new and effective therapeutic targets remains an urgent clinical need. The transcription factor <i>SALL2</i> has been shown to play distinct roles in tumorigenesis and progression, but its specific role in BRCA remains unclear. Therefore, this study investigates the effects of <i>SALL2</i> on BRCA progression.</p><p><strong>Methods: </strong><i>SALL2</i> expression in the TCGA and clinical BRCA tissue samples was analyzed. Cell and animal models were established to validate the effects of <i>SALL2</i> on BRCA cell proliferation, migration, and tumorigenicity. Molecular experiments were performed to investigate the association between NSUN2 and SALL2 in BRCA and cellular ferroptosis regulation by SALL2.</p><p><strong>Results: </strong><i>SALL2</i> is significantly overexpressed in BRCA tissues and cell lines, knocking down <i>SALL2</i> reduces BRCA cell growth, migration, and tumorigenesis <i>in vitro</i> and <i>in vivo</i> models. The m5C methyltransferase NSUN2, together with the reader protein YBX1, modifies <i>SALL2</i> mRNA with m5C, which stabilizes the transcript. <i>SALL2</i> then acts as a transcriptional repressor by binding directly to the promoter region of <i>ACSL4</i> and inhibiting its transcriptional activity. Suppression of <i>SALL2</i> activates ferroptotic cell death by lowering the antioxidant defences of GPX4/SLC7A11 and increasing the expression of <i>ACSL4</i> and <i>COX2</i>. Ferroptosis inhibitors can reverse the growth-inhibiting effects caused by <i>SALL2</i> depletion.</p><p><strong>Conclusion: </strong>In BRCA, <i>SALL2</i> is precisely regulated by m5C RNA methylation modification, further promoting cancer progression by inhibiting cell ferroptosis, suggesting its potential as a prognostic biomarker and a target for therapy.</p>\",\"PeriodicalId\":9536,\"journal\":{\"name\":\"Cancer Biology & Therapy\",\"volume\":\"27 1\",\"pages\":\"2695501\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2026-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13327353/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Biology & Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15384047.2026.2695501\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biology & Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15384047.2026.2695501","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:由于乳腺癌(BRCA)的异质性和特定分子亚型的治疗效果有限,寻找新的有效的治疗靶点仍然是迫切的临床需要。转录因子SALL2已被证明在肿瘤发生和进展中发挥着独特的作用,但其在BRCA中的具体作用尚不清楚。因此,本研究探讨了SALL2对BRCA进展的影响。方法:分析SALL2在TCGA和临床BRCA组织样本中的表达。我们建立了细胞和动物模型来验证SALL2对BRCA细胞增殖、迁移和致瘤性的影响。我们通过分子实验研究了NSUN2和SALL2在BRCA中的关联以及SALL2对细胞铁凋亡的调控。结果:SALL2在BRCA组织和细胞系中显著过表达,在体外和体内模型中,敲低SALL2可减少BRCA细胞的生长、迁移和肿瘤发生。m5C甲基转移酶NSUN2与阅读器蛋白YBX1一起用m5C修饰SALL2 mRNA,从而稳定转录物。然后,SALL2通过直接结合ACSL4的启动子区域并抑制其转录活性而作为转录抑制因子。抑制SALL2通过降低GPX4/SLC7A11的抗氧化防御能力和增加ACSL4和COX2的表达来激活铁致细胞死亡。铁下垂抑制剂可以逆转SALL2缺失引起的生长抑制作用。结论:在BRCA中,SALL2受m5C RNA甲基化修饰的精确调控,通过抑制细胞铁凋亡进一步促进癌症进展,提示其作为预后生物标志物和治疗靶点的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
NSUN2 mediates SALL2 m5C methylation to inhibit ferroptosis and promote breast cancer progression.

Background: Due to the heterogeneity of breast cancer (BRCA) and the limited therapeutic efficacy in specific molecular subtypes, identifying new and effective therapeutic targets remains an urgent clinical need. The transcription factor SALL2 has been shown to play distinct roles in tumorigenesis and progression, but its specific role in BRCA remains unclear. Therefore, this study investigates the effects of SALL2 on BRCA progression.

Methods: SALL2 expression in the TCGA and clinical BRCA tissue samples was analyzed. Cell and animal models were established to validate the effects of SALL2 on BRCA cell proliferation, migration, and tumorigenicity. Molecular experiments were performed to investigate the association between NSUN2 and SALL2 in BRCA and cellular ferroptosis regulation by SALL2.

Results: SALL2 is significantly overexpressed in BRCA tissues and cell lines, knocking down SALL2 reduces BRCA cell growth, migration, and tumorigenesis in vitro and in vivo models. The m5C methyltransferase NSUN2, together with the reader protein YBX1, modifies SALL2 mRNA with m5C, which stabilizes the transcript. SALL2 then acts as a transcriptional repressor by binding directly to the promoter region of ACSL4 and inhibiting its transcriptional activity. Suppression of SALL2 activates ferroptotic cell death by lowering the antioxidant defences of GPX4/SLC7A11 and increasing the expression of ACSL4 and COX2. Ferroptosis inhibitors can reverse the growth-inhibiting effects caused by SALL2 depletion.

Conclusion: In BRCA, SALL2 is precisely regulated by m5C RNA methylation modification, further promoting cancer progression by inhibiting cell ferroptosis, suggesting its potential as a prognostic biomarker and a target for therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Biology & Therapy
Cancer Biology & Therapy 医学-肿瘤学
CiteScore
7.00
自引率
0.00%
发文量
60
审稿时长
2.3 months
期刊介绍: Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书